Your browser doesn't support javascript.
loading
Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury.
Tsuji, Hidenori; Wang, Wei; Sunil, Joshi; Shimizu, Nobutaka; Yoshimura, Kazuhiro; Uemura, Hirotsugu; Peck, Ammon B; Khan, Saeed R.
Afiliação
  • Tsuji H; Department of Urology, Faculty of Medicine, Kinki University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan.
  • Wang W; Department of Pathology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Sunil J; Department of Pathology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Shimizu N; Department of Pathology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Yoshimura K; Department of Urology, Faculty of Medicine, Kinki University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan. nsimizu810@yahoo.co.jp.
  • Uemura H; Department of Urology, Faculty of Medicine, Kinki University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan.
  • Peck AB; Department of Urology, Faculty of Medicine, Kinki University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan.
  • Khan SR; Department of Pathology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
World J Urol ; 34(1): 89-95, 2016 Jan.
Article em En | MEDLINE | ID: mdl-25981400
ABSTRACT
INTRODUCTION AND

OBJECTIVES:

Reactive oxygen species (ROS) are produced during the interaction between oxalate/calcium oxalate monohydrate (COM) crystals and renal epithelial cells and are responsible for the various cellular responses through the activation of NADPH oxidase (Nox). Ox and COM also activate the renin-angiotensin-aldosterone system (RAAS). Aldosterone stimulates ROS production through activation of Nox with the involvement of mineralocorticoid receptor (MR), Rac1 and mitogen-activated protein kinases (MAPK). We investigated RAAS pathways in vivo in an animal model of hyperoxaluria and in vitro by exposing renal epithelial cells to COM crystals.

METHODS:

Hyperoxaluria was induced in male SD rats by administering ethylene glycol. One group of rats was additionally given spironolactone. Total RNA was extracted and subjected to genomic microarrays to obtain global transcriptome data. Normal rat kidney cell line (NRK-52E) was incubated with aldosterone(10(-7) M) and COM(67 µg/cm(2)) with or without spironolactone(10(-5) M), a selective inhibitor of SRC family of kinases; protein phosphatase 2(pp2) (10(-5) M) and Nox inhibitor; diphenylene iodonium (DPI) (10(-5) M).

RESULTS:

Relative expression of genes encoding for AGT, angiotensin receptors 1b and 2, Renin 1, Cyp11b, HSD11B2, Nr3c2, NOx4 and Rac1 was upregulated in the kidneys of rats with hyperoxaluria. Treatment with spironolactone reversed the effect of hyperoxaluria. Both aldosterone and COM crystals activated Nox and Rac1 expression in NRK52E, while spironolactone inhibited Nox and Rac1 expression. Increased Rac1 expression was significantly attenuated by treatment with PP2 and spironolactone.

CONCLUSIONS:

Results indicate that hyperoxaluria-induced production of ROS, injury and inflammation are in part associated with the activation of Nox through renin-angiotensin-aldosterone pathway.
Assuntos
Oxalato de Cálcio/metabolismo; Hiperoxalúria/genética; NADPH Oxidases/metabolismo; RNA Mensageiro/metabolismo; Sistema Renina-Angiotensina/genética; 11-beta-Hidroxiesteroide Desidrogenase Tipo 2/efeitos dos fármacos; 11-beta-Hidroxiesteroide Desidrogenase Tipo 2/genética; 11-beta-Hidroxiesteroide Desidrogenase Tipo 2/metabolismo; Angiotensinogênio/efeitos dos fármacos; Angiotensinogênio/genética; Angiotensinogênio/metabolismo; Animais; Linhagem Celular; Citocromo P-450 CYP11B2/efeitos dos fármacos; Citocromo P-450 CYP11B2/genética; Citocromo P-450 CYP11B2/metabolismo; Modelos Animais de Doenças; Inibidores Enzimáticos/farmacologia; Etilenoglicol/toxicidade; Perfilação da Expressão Gênica; Hiperoxalúria/induzido quimicamente; Hiperoxalúria/metabolismo; Masculino; Antagonistas de Receptores de Mineralocorticoides/farmacologia; NADPH Oxidase 4; NADPH Oxidases/efeitos dos fármacos; NADPH Oxidases/genética; Oniocompostos/farmacologia; Proteína Fosfatase 2/farmacologia; RNA Mensageiro/efeitos dos fármacos; Ratos; Ratos Sprague-Dawley; Receptores de Angiotensina/efeitos dos fármacos; Receptores de Angiotensina/genética; Receptores de Angiotensina/metabolismo; Receptores de Mineralocorticoides/efeitos dos fármacos; Receptores de Mineralocorticoides/genética; Receptores de Mineralocorticoides/metabolismo; Renina/efeitos dos fármacos; Renina/genética; Renina/metabolismo; Sistema Renina-Angiotensina/efeitos dos fármacos; Espironolactona/farmacologia; Esteroide 11-beta-Hidroxilase/efeitos dos fármacos; Esteroide 11-beta-Hidroxilase/genética; Esteroide 11-beta-Hidroxilase/metabolismo; Proteínas rac1 de Ligação ao GTP/efeitos dos fármacos; Proteínas rac1 de Ligação ao GTP/genética; Proteínas rac1 de Ligação ao GTP/metabolismo
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Renina-Angiotensina / Hiperoxalúria / Oxalato de Cálcio / RNA Mensageiro / NADPH Oxidases Idioma: En Revista: World J Urol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Renina-Angiotensina / Hiperoxalúria / Oxalato de Cálcio / RNA Mensageiro / NADPH Oxidases Idioma: En Revista: World J Urol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão